ATXI
Morgan Stanley’s Avenue Therapeutics, Inc. Common Stock ATXI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-276
| Closed | -$195 | – | 7927 |
|
|
2023
Q3 | $195 | Sell |
276
-138
| -33% | -$98 | ﹤0.01% | 7389 |
|
|
2023
Q2 | $484 | Hold |
414
| – | – | ﹤0.01% | 7379 |
|
|
2023
Q1 | $482 | Sell |
414
-2,918
| -88% | -$3.4K | ﹤0.01% | 7442 |
|
|
2022
Q4 | $3.87K | Buy |
3,332
+1,858
| +126% | +$2.16K | ﹤0.01% | 7218 |
|
|
2022
Q3 | $15K | Buy |
+1,474
| New | +$15K | ﹤0.01% | 6932 |
|
|
2022
Q2 | – | Sell |
-1,002
| Closed | – | – | 8029 |
|
|
2022
Q1 | $0 | Buy |
1,002
+968
| +2,847% | – | ﹤0.01% | 8161 |
|
|
2021
Q4 | $0 | Sell |
34
-88
| -72% | – | ﹤0.01% | 8142 |
|
|
2021
Q3 | $0 | Sell |
122
-61
| -33% | – | ﹤0.01% | 8051 |
|
|
2021
Q2 | $0 | Buy |
183
+108
| +144% | – | ﹤0.01% | 7823 |
|
|
2021
Q1 | $0 | Sell |
75
-24,909
| -100% | – | ﹤0.01% | 7588 |
|
|
2020
Q4 | $149K | Buy |
24,984
+2,278
| +10% | +$13.6K | ﹤0.01% | 5738 |
|
|
2020
Q3 | $246K | Buy |
22,706
+16,584
| +271% | +$180K | ﹤0.01% | 5002 |
|
|
2020
Q2 | $66K | Buy |
6,122
+1,431
| +31% | +$15.4K | ﹤0.01% | 5576 |
|
|
2020
Q1 | $42K | Buy |
4,691
+1,506
| +47% | +$13.5K | ﹤0.01% | 5536 |
|
|
2019
Q4 | $31K | Buy |
3,185
+2,000
| +169% | +$19.5K | ﹤0.01% | 5991 |
|
|
2019
Q3 | $7K | Buy |
+1,185
| New | +$7K | ﹤0.01% | 6305 |
|
|
2018
Q2 | – | Sell |
-10
| Closed | – | – | 6773 |
|
|
2018
Q1 | $0 | Sell |
10
-11
| -52% | – | ﹤0.01% | 6718 |
|
|
2017
Q4 | $0 | Sell |
21
-775
| -97% | – | ﹤0.01% | 6672 |
|
|
2017
Q3 | $4K | Buy |
+796
| New | +$4K | ﹤0.01% | 6332 |
|